Literature DB >> 24585422

The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease.

Masato Yoneda1, Emmanuel Thomas, Yoshio Sumida, Yuichiro Eguchi, Eugene R Schiff.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24585422     DOI： 10.1002/hep.27097

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  11 in total

1.  A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease.

Authors:  Jagpal Singh Klair; Ju Dong Yang; Manal F Abdelmalek; Cynthia D Guy; Ryan M Gill; Katherine Yates; Aynur Unalp-Arida; Joel E Lavine; Jeanne M Clark; Anna Mae Diehl; Ayako Suzuki
Journal:  Hepatology       Date:  2016-04-05       Impact factor: 17.425

Review 2.  Liver disease in menopause.

Authors:  Carla W Brady
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

Review 3.  Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones.

Authors:  K Pafili; S A Paschou; E Armeni; S A Polyzos; D G Goulis; I Lambrinoudaki
Journal:  J Endocrinol Invest       Date:  2022-03-18       Impact factor: 5.467

4.  Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis.

Authors:  Ju Dong Yang; Manal F Abdelmalek; Cynthia D Guy; Ryan M Gill; Joel E Lavine; Katherine Yates; Jagpal Klair; Norah A Terrault; Jeanne M Clark; Aynur Unalp-Arida; Anna Mae Diehl; Ayako Suzuki
Journal:  Clin Gastroenterol Hepatol       Date:  2016-08-12       Impact factor: 11.382

Review 5.  NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.

Authors:  Stefano Ballestri; Fabio Nascimbeni; Enrica Baldelli; Alessandra Marrazzo; Dante Romagnoli; Amedeo Lonardo
Journal:  Adv Ther       Date:  2017-05-19       Impact factor: 3.845

Review 6.  Epidemiology: Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan.

Authors:  Yoshio Sumida; Toshihide Shima; Yasuhide Mitsumoto; Takafumi Katayama; Atsushi Umemura; Kanji Yamaguchi; Yoshito Itoh; Masashi Yoneda; Takeshi Okanoue
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

Review 7.  Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research.

Authors:  Amedeo Lonardo; Ayako Suzuki
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

Review 8.  Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.

Authors:  Chanbin Lee; Jieun Kim; Youngmi Jung
Journal:  Cells       Date:  2019-10-15       Impact factor: 6.600

Review 9.  Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling.

Authors:  Sara Della Torre
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-18       Impact factor: 5.555

Review 10.  NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment.

Authors:  Johanna K DiStefano
Journal:  Endocrinology       Date:  2020-10-01       Impact factor: 4.736
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.